Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    HYPOALPHALIPOPROTEINEMIA, PRIMARY
Show Display Options
Rank Status Study
1 Recruiting CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases
Condition: Familial Hypoalphalipoproteinemia
Interventions: Drug: CER-001;   Drug: Placebo
2 Completed High-Density Lipoprotein (HDL) Treatment Study
Conditions: Coronary Arteriosclerosis;   Hypoalphalipoproteinemias;   Genetic Diseases, Inborn
Intervention: Drug: Atorvastatin; Fenofibrate; Niacin

Indicates status has not been verified in more than two years